You are connecting from Lake Geneva Public Library, please login or register to take advantage of your institution's Ground News Plan.
Published 1 month ago • loading... • Updated 1 month ago
Ocular Therapeutix: Q2 Earnings Snapshot
The biotechnology company posted $13.5 million in revenue and a 35-cent-per-share loss, both better than analysts expected.
Summary
BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $78.8 million in its second quarter. The Bedford…